Biological Impact of Recent Guidelines on Parenteral Nutrition in Preterm Infants

Isabelle Guellec1, Géraldine Gascoin, Alain Beuchee

  • 1*Neonatal and Pediatric Intensive Care Unit, CHU Armand Trousseau, Assistance Publique-Hôpitaux de Paris, Paris †Neonatal Intensive Care Unit, CHU Angers, Angers ‡Neonatal Intensive Care Unit, Pôle Médico-Chirurgical de Pédiatrie et de Génétique Clinique, CHU Rennes, Rennes §Division of Neonatology, AP-HM, Aix-Marseille University, Marseille ||Neonatal Intensive Care Unit, Pôle Femme Couple Enfant, CHU Amiens, Amiens ¶Neonatal and Pediatric Intensive Care Unit, CHU Félix Guyon, La Réunion #Neonatal Intensive Care Unit Port-Royal, Groupe Hospitalier Cochin-Broca-Hôtel Dieu, Assistance Publique-Hôpitaux de Paris, Paris **Neonatal Intensive Care Unit, Groupe Hospitalier Robert Debré, Assistance Publique-Hôpitaux de Paris, Paris, France.

Insights

New parenteral nutrition (PN) guidelines for preterm infants may disrupt ionic homeostasis, potentially causing metabolic acidosis and hypophosphatemia. Close monitoring is crucial for preventing adverse effects in these vulnerable neonates.

Area of Science:

  • Neonatalogy
  • Pediatric Nutrition
  • Biochemistry

Background:

  • Recent guidelines advocate for early parenteral nutrition (PN) with high protein and caloric intake in preterm neonates.
  • This approach aims to optimize growth but may impact infant homeostasis during early postnatal weeks.

Purpose of the Study:

  • To evaluate the potential influence of updated PN guidelines on the homeostasis of very preterm infants.
  • To identify potential adverse effects associated with early high-protein and high-caloric PN in neonates.

Main Methods:

  • Systematic review of relevant literature.
  • Analysis of PubMed and recent clinical guidelines.
  • Expert review by investigators from French perinatal centers.

Main Results:

  • Updated PN recommendations may lead to metabolic acidosis (amino acid gap, hyperchloremic, ammonia acidosis).
  • High amino acid intake can cause hypophosphatemia and hypercalcemia, mimicking 'repeat feeding-like syndrome', preventable with phosphorus.
  • Early high-dose amino acid infusions appear safe for preterm infant renal function, but further research on protein intolerance markers is needed.

Conclusions:

  • While beneficial for growth, optimal PN according to new guidelines may disrupt ionic homeostasis in very preterm infants.
  • Clinicians must implement vigilant monitoring to prevent and manage potential adverse effects on homeostasis.
Abstract

Related Concept Videos

Parentral Nutrition: Centeral and Peripheral Parental Nutrition01:27

Parentral Nutrition: Centeral and Peripheral Parental Nutrition

Parenteral Nutrition (PN) delivers essential nutrients directly into the bloodstream, bypassing the digestive system. It is commonly used for individuals with severe digestive disorders or conditions that prevent normal nutrient absorption.
PN can be administered through two primary routes:
1. Central Parenteral Nutrition (CPN):
CPN involves delivering a high concentration of nutrients through a large vein. This is typically achieved using a Peripherally Inserted Central Catheter (PICC) or,...
1.7K
Pharmacokinetics in Pediatric Patients: Overview and Drug Absorption01:23

Pharmacokinetics in Pediatric Patients: Overview and Drug Absorption

Understanding the physiological differences in the pediatric population is crucial for effective pharmacotherapy. Neonates, infants, and children exhibit significant variations in gastric pH, gastric emptying time, intestinal transit time, and biliary function. These variations profoundly affect oral drug absorption, necessitating a nuanced approach to pediatric dosing.Neonates present with a unique physiological profile, having a gastric pH greater than 4 and faster and more irregular gastric...
776
Pharmacokinetics in Pediatric Patients: Drug Distribution01:17

Pharmacokinetics in Pediatric Patients: Drug Distribution

Drug distribution in the pediatric population exhibits unique challenges and considerations due to the physiological differences between children, particularly neonates and infants, and adults. A crucial aspect of pediatric pharmacology is understanding how these differences impact the pharmacokinetics of various drugs, necessitating age-specific dosing strategies to ensure efficacy and safety.Neonates and infants have a higher total body water content, ~75%–90% of their body weight,...
486
Enteral Nutrition II: Nasointestinal and Gastrostomy Feeding01:15

Enteral Nutrition II: Nasointestinal and Gastrostomy Feeding

Enteral nutrition encompasses various methods of delivering nutrition directly to the gastrointestinal (GI) tract, bypassing traditional oral intake. It is particularly beneficial for patients who cannot eat by mouth but have a functioning digestive system. Key methods include nasointestinal feeding, gastrostomy, and jejunostomy, each suited to different clinical scenarios based on the patient's needs and condition.
Nasointestinal Feeding
Nasointestinal feeding involves placing a tube...
1.7K
Enteral Nutrition I: Orogastric and Nasogastric Feeding01:26

Enteral Nutrition I: Orogastric and Nasogastric Feeding

Enteral nutrition delivers nutrients directly to the stomach or small intestine through a tube. This method is appropriate for patients who cannot eat but still have a functioning digestive system. It is also beneficial for individuals with swallowing difficulties, anorexia, malabsorption, or those who have undergone gastrointestinal (GI) surgery.
Orogastric (OG) and nasogastric (NG) feeding are two standard methods used for enteral nutrition. Enteral nutrition is often preferred over...
2.5K
Pharmacokinetics in Pediatric Patients: Drug Excretion01:26

Pharmacokinetics in Pediatric Patients: Drug Excretion

In pediatric medicine, understanding the renal function and drug elimination nuances is crucial for administering safe and effective treatments. Newborns, in particular, display markedly slower renal functions than adults, profoundly affecting how drugs are cleared from their bodies. This slower drug clearance requires clinicians to extend the dosing intervals for many medications to prevent drug accumulation and toxicity while ensuring therapeutic efficacy.One key area where these adjustments...
380